The presence of KRAS sequence variation, one of the most common surrogates of tumor biological factors, appeared to trigger a distinct pattern of intrahepatic tumor growth and dissemination,32 which may affect the beneficial outcome of simultaneous resection in this patient subgroup. This evidence concerns the gene KRAS and neoplasm.